{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T09:57:40Z","timestamp":1718877460634},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,9,29]],"date-time":"2009-09-29T00:00:00Z","timestamp":1254182400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s11892-009-0053-2","type":"journal-article","created":{"date-parts":[[2009,9,28]],"date-time":"2009-09-28T09:47:41Z","timestamp":1254131261000},"page":"335-341","source":"Crossref","is-referenced-by-count":10,"title":["What is the best treatment for prediabetes?"],"prefix":"10.1007","volume":"9","author":[{"given":"Morali D.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan J.","family":"Garber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,29]]},"reference":[{"key":"53_CR1","unstructured":"Centers for Disease Control: Number of people with diabetes increases to 24 million [press release]. Available at http:\/\/www.cdc.gov\/media\/pressrel\/2008\/r080624.htm . Accessed July 21, 2008."},{"key":"53_CR2","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection, Evaluation,Treatment of High Blood Cholesterol in Adults","year":"2001","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486\u20132497.","journal-title":"JAMA"},{"key":"53_CR3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.diabres.2006.02.008","volume":"73","author":"R.J. Tapp","year":"2006","unstructured":"Tapp RJ, Zimmet PZ, Harper CA, et al.; AusDiab Study Group: Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia. Diabetes Res Clin Pract 2006, 73:315\u2013321.","journal-title":"Diabetes Res Clin Pract"},{"key":"53_CR4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0140-6736(08)60343-8","volume":"371","author":"T.Y. Wong","year":"2008","unstructured":"Wong TY, Liew G, Tapp RJ, et al.: Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet 2008, 371:736\u2013743. (Published erratum appears in Lancet 2008, 371:1838.)","journal-title":"Lancet"},{"key":"53_CR5","unstructured":"International Diabetes Federation: Diabetes Atlas: Prevalence. Available at http:\/\/www.eatlas.idf.org . Accessed August 1, 2008."},{"key":"53_CR6","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/dc08-9017","volume":"31","author":"American Diabetes Association","year":"2008","unstructured":"American Diabetes Association: Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008, 31:596\u2013615. (Published erratum appears in Diabetes Care 2008, 31:1271.)","journal-title":"Diabetes Care"},{"key":"53_CR7","unstructured":"Centers for Disease Control and Prevention: National diabetes fact sheet: general information and national estimates on diabetes in the Unites States, 2007. Available at http:\/\/www.cdc.gov\/diabetes\/pubs\/pdf\/ndfs_2007.pdf . Accessed July 30, 2008."},{"key":"53_CR8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bmj.39063.689375.55","volume":"334","author":"C.L. Gillies","year":"2007","unstructured":"Gillies CL, Abrams KR, Lambert PC, et al.: Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007, 334:299.","journal-title":"BMJ"},{"key":"53_CR9","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2337\/dc07-1868","volume":"31","author":"G.R. Dagenais","year":"2008","unstructured":"DREAM Trial Investigators, Dagenais GR, Gerstein HC, et al.: Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the diabetes reduction assessment with ramipril and rosiglitazone medication (DREAM) trial. Diabetes Care 2008, 31:1007\u20131014.","journal-title":"Diabetes Care"},{"issue":"Suppl1","key":"53_CR10","first-page":"1","volume":"13","author":"AACE Diabetes Mellitus Clinical Practice Guidelines Task Force","year":"2007","unstructured":"AACE Diabetes Mellitus Clinical Practice Guidelines Task Force: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007, 13(Suppl 1):1\u201368.","journal-title":"Endocr Pract"},{"issue":"Suppl1","key":"53_CR11","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.2337\/dc08-S012","volume":"31","author":"American Diabetes Association","year":"2008","unstructured":"American Diabetes Association: Standards of medical care in diabetes-2008. Diabetes Care 2008, 31(Suppl 1):S12\u2013S54.","journal-title":"Diabetes Care"},{"key":"53_CR12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/CIRCULATIONAHA.106.685628","volume":"116","author":"E.L. Barr","year":"2007","unstructured":"Barr EL, Zimmet PZ, Welborn TA, et al.: Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007, 116:151\u2013157.","journal-title":"Circulation"},{"key":"53_CR13","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.2337\/diacare.26.11.3153","volume":"26","author":"C. Lorenzo","year":"2003","unstructured":"Lorenzo C, Okoloise M, Williams K, et al.: The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003, 26:3153\u20133159.","journal-title":"Diabetes Care"},{"key":"53_CR14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"W.C. Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Diabetes Prevention Program Research Group. N Engl J Med 2002, 346:393\u2013403.","journal-title":"N Engl J Med"},{"key":"53_CR15","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.2337\/diabetes.54.4.1150","volume":"54","author":"W.C. Knowler","year":"2005","unstructured":"Knowler WC, Hamman RF, Edelstein SL, et al.: Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes Prevention Program Research Group. Diabetes 2005, 54:1150\u20131156.","journal-title":"Diabetes"},{"issue":"Suppl1","key":"53_CR16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4158\/EP.12.S1.25","volume":"12","author":"J.L. Chiasson","year":"2006","unstructured":"Chiasson JL: Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial. Endocr Pract 2006, 12(Suppl 1):25\u201330.","journal-title":"Endocr Pract"},{"key":"53_CR17","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4158\/EP.14.7.933","volume":"14","author":"A.J. Garber","year":"2008","unstructured":"Garber AJ, Handelsman Y, Einhorn D, et al.: Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract 2008, 14:933\u2013946.","journal-title":"Endocr Pract"},{"key":"53_CR18","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME","year":"2008","unstructured":"Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al.: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545\u20132559.","journal-title":"N Engl J Med"},{"key":"53_CR19","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2337\/dc05-1709","volume":"29","author":"R.T. Ackermann","year":"2006","unstructured":"Ackermann RT, Marrero DG, Hicks KA, et al.: An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes. Diabetes Care 2006, 29:1237\u20131241.","journal-title":"Diabetes Care"},{"key":"53_CR20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","volume":"27","author":"J.S. Torgerson","year":"2004","unstructured":"Torgerson JS, Hauptman J, Boldrin MN, Sj\u00f6str\u00f6m L: XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients Diabetes Care 2004, 27:155\u2013161. (Published erratum appears in Diabetes Care 2004, 27:856.)","journal-title":"Diabetes Care"},{"key":"53_CR21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2337\/diacare.26.1.125","volume":"26","author":"S.J. McNulty","year":"2003","unstructured":"McNulty SJ, Ur E, Williams G; Multicenter Sibutramine Study Group: A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin. Diabetes Care 2003, 26:125\u2013131.","journal-title":"Diabetes Care"},{"key":"53_CR22","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/S0140-6736(06)69571-8","volume":"368","author":"A.J. Scheen","year":"2006","unstructured":"Scheen AJ, Finer N, Hollander P, et al.: Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomized controlled study Lancet 2006, 368:1660\u20131672. (Published erratum appears in Lancet 2006, 368:1650.)","journal-title":"Lancet"},{"key":"53_CR23","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0140-6736(07)61705-X","volume":"370","author":"P.B. Mitchell","year":"2007","unstructured":"Mitchell PB, Morris MJ: Depression and anxiety with rimonabant. Lancet 2007, 370:1671\u20131672.","journal-title":"Lancet"},{"key":"53_CR24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2337\/dc07-1441","volume":"31","author":"K.M. Utzschneider","year":"2008","unstructured":"Utzschneider KM, Tong J, Montgomery B, et al.: The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta cell function and insulin sensitivity in subjects with impaired fasting glucose. Diabetes Care 2008, 31:108\u2013113.","journal-title":"Diabetes Care"},{"key":"53_CR25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/jc.2006-1516","volume":"92","author":"M. Rosenbaum","year":"2007","unstructured":"Rosenbaum M, Nonas C, Weil R, et al.: El Camino Diabetes Prevention Group: School-based intervention acutely improves insulin sensitivity and decreases inflammatory markers and body in junior high school students J Clin Endocrinol Metab 2007, 92:504\u2013508.","journal-title":"J Clin Endocrinol Metab"},{"key":"53_CR26","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1161\/CIRCULATIONAHA.107.181946","volume":"115","author":"B.W. McCrindle","year":"2007","unstructured":"McCrindle BW, Urbina EM, Dennison BA, et al.; American Heart Association, Hypertension, and Obesity in Youth Committee; American Heart Association Council of Cardiovascular Disease in the Young; American Heart Association Council on Cardiovascular Nursing: Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 2007, 115:1948\u20131967.","journal-title":"Circulation"},{"key":"53_CR27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1542\/peds.2008-1349","volume":"122","author":"S.R. Daniels","year":"2008","unstructured":"Daniels SR, Greer FR; Committee on Nutrition: Lipid screening and cardiovascular health in childhood. Pediatrics 2008, 122:198\u2013208.","journal-title":"Pediatrics"},{"key":"53_CR28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.7326\/0003-4819-142-5-200503010-00007","volume":"142","author":"W.H. Herman","year":"2005","unstructured":"Herman WH, Hoerger TJ, Brandle M, et al.: The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Diabetes Prevention Program Research Group. Ann Intern Med 2005, 142:323\u2013332.","journal-title":"Ann Intern Med"},{"key":"53_CR29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"I.M. Stratton","year":"2000","unstructured":"Stratton IM, Adler AI, Neil HA, et al.: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 321:405\u2013412.","journal-title":"BMJ"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-009-0053-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-009-0053-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-009-0053-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:56:21Z","timestamp":1559433381000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-009-0053-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,29]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["53"],"URL":"https:\/\/doi.org\/10.1007\/s11892-009-0053-2","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,29]]}}}